CAR--话题@MedSci

#CAR-#

459篇内容 | 2247人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1781480, encodeId=b6951e8148026, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=【4月19日(周二)19:00星光奕奕】CAR-T中国病例分享会即将开始！, objectType=article, longId=724282, objectId=5648e2428287, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5648e2428287, replyNumber=0, likeNumber=64, createdTime=2022-12-05, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5648e2428287, moduleTitle=【4月19日(周二)19:00星光奕奕】CAR-T中国病例分享会即将开始！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5648e2428287)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781497, encodeId=77c41e8149783, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=郑大一附院张毅团队的CAR-T细胞治疗新技术转让8000万元！创河南省技术转让新纪录！, objectType=article, longId=730544, objectId=0116e3054422, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0116e3054422, replyNumber=0, likeNumber=82, createdTime=2022-10-18, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0116e3054422, moduleTitle=郑大一附院张毅团队的CAR-T细胞治疗新技术转让8000万元！创河南省技术转让新纪录！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0116e3054422)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781482, encodeId=9d301e81482ee, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=Cell：重磅！下一代更智能的细胞疗法出炉！表达模块化SNIPR受体的CAR-T细胞可高效杀死实体瘤，同时减少毒副作用, objectType=article, longId=724648, objectId=6f1ce2464888, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6f1ce2464888, replyNumber=0, likeNumber=72, createdTime=2022-06-10, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6f1ce2464888, moduleTitle=Cell：重磅！下一代更智能的细胞疗法出炉！表达模块化SNIPR受体的CAR-T细胞可高效杀死实体瘤，同时减少毒副作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6f1ce2464888)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781469, encodeId=eede1e8146961, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=Cell子刊：陈斯迪团队利用CRISPR筛选，发现增强CAR-T效果新手段, objectType=article, longId=300611, objectId=b2bc30061145, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b2bc30061145, replyNumber=0, likeNumber=116, createdTime=2023-02-20, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b2bc30061145, moduleTitle=Cell子刊：陈斯迪团队利用CRISPR筛选，发现增强CAR-T效果新手段, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b2bc30061145)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781485, encodeId=30151e814851a, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=通用型CAR-NK用于复发/难治性B细胞淋巴瘤，3/6例获得CR, objectType=article, longId=725533, objectId=55e3e255332a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=55e3e255332a, replyNumber=0, likeNumber=73, createdTime=2023-02-28, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=55e3e255332a, moduleTitle=通用型CAR-NK用于复发/难治性B细胞淋巴瘤，3/6例获得CR, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=55e3e255332a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781453, encodeId=69921e814533a, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=UHRF1 基因在人卵巢癌细胞株 OVCAR-3 中的表达及意义, objectType=article, longId=220977, objectId=01782209e76c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=01782209e76c, replyNumber=0, likeNumber=36, createdTime=2022-05-08, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=01782209e76c, moduleTitle=UHRF1 基因在人卵巢癌细胞株 OVCAR-3 中的表达及意义, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=01782209e76c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781460, encodeId=20c71e814605a, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=Cancers：CAR-T细胞中的TNFRSF共刺激域, objectType=article, longId=294919, objectId=551329491926, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=551329491926, replyNumber=0, likeNumber=72, createdTime=2022-05-27, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=551329491926, moduleTitle=Cancers：CAR-T细胞中的TNFRSF共刺激域, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=551329491926)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781476, encodeId=02151e81476f5, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=Nature Cancer：CAR-T治疗神经内分泌肿瘤和胃肠间质瘤的安全靶点——CDH17（LI钙粘蛋白）, objectType=article, longId=723586, objectId=f925e23586f7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f925e23586f7, replyNumber=0, likeNumber=91, createdTime=2022-08-18, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f925e23586f7, moduleTitle=Nature Cancer：CAR-T治疗神经内分泌肿瘤和胃肠间质瘤的安全靶点——CDH17（LI钙粘蛋白）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f925e23586f7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781475, encodeId=aaae1e8147592, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=CAR-T细胞疗法Yescarta获得FDA批准用于早期治疗淋巴瘤, objectType=article, longId=723516, objectId=7576e23516c3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7576e23516c3, replyNumber=0, likeNumber=65, createdTime=2022-04-06, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7576e23516c3, moduleTitle=CAR-T细胞疗法Yescarta获得FDA批准用于早期治疗淋巴瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7576e23516c3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781506, encodeId=07791e815063c, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=【7月21日(周四)14:00星光奕奕】CAR-T中国病例分享会即将开始！, objectType=article, longId=732804, objectId=af01e32804fe, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=af01e32804fe, replyNumber=0, likeNumber=67, createdTime=2023-03-16, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=af01e32804fe, moduleTitle=【7月21日(周四)14:00星光奕奕】CAR-T中国病例分享会即将开始！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=af01e32804fe)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781464, encodeId=8e991e8146493, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=南京传奇生物已暂停CAR-T疗法LB1901的I期临床试验, objectType=article, longId=299008, objectId=40752990089a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=40752990089a, replyNumber=0, likeNumber=84, createdTime=2022-09-22, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=40752990089a, moduleTitle=南京传奇生物已暂停CAR-T疗法LB1901的I期临床试验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=40752990089a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781452, encodeId=8c791e81452e9, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=Science Translational Medicine：敲除这个表观遗传基因，让CAR-T更有效, objectType=article, longId=220845, objectId=8e4a22084505, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8e4a22084505, replyNumber=0, likeNumber=80, createdTime=2022-02-06, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8e4a22084505, moduleTitle=Science Translational Medicine：敲除这个表观遗传基因，让CAR-T更有效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8e4a22084505)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781511, encodeId=a70a1e81511b5, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=影响CAR-T细胞持久性的因素及应对策略, objectType=article, longId=733651, objectId=ce45e33651a2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ce45e33651a2, replyNumber=0, likeNumber=75, createdTime=2022-09-02, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ce45e33651a2, moduleTitle=影响CAR-T细胞持久性的因素及应对策略, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ce45e33651a2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781494, encodeId=a2c21e814945b, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=我国第一款CAR-T抗癌药物上市一周年，超200名患者使用，临床疗效如何？, objectType=article, longId=729742, objectId=354ce2974234, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=354ce2974234, replyNumber=0, likeNumber=68, createdTime=2022-09-13, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=354ce2974234, moduleTitle=我国第一款CAR-T抗癌药物上市一周年，超200名患者使用，临床疗效如何？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=354ce2974234)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781447, encodeId=0e0a1e814477b, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=基因编辑的未来遭质疑，因严重安全问题，FDA暂停基于基因编辑的CAR-T临床试验！, objectType=article, longId=218752, objectId=ef37218e52f5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ef37218e52f5, replyNumber=0, likeNumber=66, createdTime=2021-10-27, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ef37218e52f5, moduleTitle=基因编辑的未来遭质疑，因严重安全问题，FDA暂停基于基因编辑的CAR-T临床试验！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ef37218e52f5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781518, encodeId=c9f71e81518ac, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=【8月17日(周三)19:10星光奕奕】CAR-T桥接病例专场即将开始！, objectType=article, longId=736118, objectId=2c79e3611878, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2c79e3611878, replyNumber=0, likeNumber=59, createdTime=2022-10-22, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2c79e3611878, moduleTitle=【8月17日(周三)19:10星光奕奕】CAR-T桥接病例专场即将开始！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2c79e3611878)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781459, encodeId=7b671e81459b1, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=异基因CAR-T细胞治疗的临床前景, objectType=article, longId=293716, objectId=74cb293e16b3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=74cb293e16b3, replyNumber=0, likeNumber=58, createdTime=2022-05-02, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=74cb293e16b3, moduleTitle=异基因CAR-T细胞治疗的临床前景, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=74cb293e16b3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781449, encodeId=03181e814497c, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=Nature重磅：CAR-T治疗实体瘤迎重大突破，新一代疗法或将成癌症克星, objectType=article, longId=220055, objectId=08a7220055a5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=08a7220055a5, replyNumber=0, likeNumber=69, createdTime=2022-02-15, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=08a7220055a5, moduleTitle=Nature重磅：CAR-T治疗实体瘤迎重大突破，新一代疗法或将成癌症克星, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=08a7220055a5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781507, encodeId=f8a41e8150773, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=Molecular Therapy-Oncolytics：李鹏/李扬秋合作发现提升CAR-T细胞抗异质性肿瘤活性新方法, objectType=article, longId=733032, objectId=c71fe3303267, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c71fe3303267, replyNumber=0, likeNumber=69, createdTime=2023-03-27, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c71fe3303267, moduleTitle=Molecular Therapy-Oncolytics：李鹏/李扬秋合作发现提升CAR-T细胞抗异质性肿瘤活性新方法, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c71fe3303267)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781470, encodeId=ba2f1e81470f6, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=【Nature】憋大招！重新编程免疫细胞，助力CAR-T攻克实体瘤！, objectType=article, longId=301070, objectId=4c883010e076, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4c883010e076, replyNumber=0, likeNumber=64, createdTime=2022-04-03, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4c883010e076, moduleTitle=【Nature】憋大招！重新编程免疫细胞，助力CAR-T攻克实体瘤！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4c883010e076)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

CAR-

2020-05-29

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

【4月19日(周二)19:00星光奕奕】CAR-T中国病例分享会即将开始！

2022-12-05

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

郑大一附院张毅团队的CAR-T细胞治疗新技术转让8000万元！创河南省技术转让新纪录！

2022-10-18

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

Cell：重磅！下一代更智能的细胞疗法出炉！表达模块化SNIPR受体的CAR-T细胞可高效杀死实体瘤，同时减少毒副作用

2022-06-10

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

Cell子刊：陈斯迪团队利用CRISPR筛选，发现增强CAR-T效果新手段

2023-02-20

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

通用型CAR-NK用于复发/难治性B细胞淋巴瘤，3/6例获得CR

2023-02-28

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

UHRF1 基因在人卵巢癌细胞株 OVCAR-3 中的表达及意义

2022-05-08

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

Cancers：CAR-T细胞中的TNFRSF共刺激域

2022-05-27

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

Nature Cancer：CAR-T治疗神经内分泌肿瘤和胃肠间质瘤的安全靶点——CDH17（LI钙粘蛋白）

2022-08-18

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

CAR-T细胞疗法Yescarta获得FDA批准用于早期治疗淋巴瘤

2022-04-06

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

【7月21日(周四)14:00星光奕奕】CAR-T中国病例分享会即将开始！

2023-03-16

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

南京传奇生物已暂停CAR-T疗法LB1901的I期临床试验

2022-09-22

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

Science Translational Medicine：敲除这个表观遗传基因，让CAR-T更有效

2022-02-06

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

影响CAR-T细胞持久性的因素及应对策略

2022-09-02

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

我国第一款CAR-T抗癌药物上市一周年，超200名患者使用，临床疗效如何？

2022-09-13

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

基因编辑的未来遭质疑，因严重安全问题，FDA暂停基于基因编辑的CAR-T临床试验！

2021-10-27

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

【8月17日(周三)19:10星光奕奕】CAR-T桥接病例专场即将开始！

2022-10-22

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

异基因CAR-T细胞治疗的临床前景

2022-05-02

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

Nature重磅：CAR-T治疗实体瘤迎重大突破，新一代疗法或将成癌症克星

2022-02-15

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

Molecular Therapy-Oncolytics：李鹏/李扬秋合作发现提升CAR-T细胞抗异质性肿瘤活性新方法

2023-03-27

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

【Nature】憋大招！重新编程免疫细胞，助力CAR-T攻克实体瘤！

2022-04-03

科室
- - 订阅+
  - 更多科室
工具
服务